(Q44609815)

4 December 2017

Glucose degradation products (GDP) retard remesothelialization independently of D-glucose concentration (English)

1 reference

4 December 2017

Glucose degradation products (GDP) retard remesothelialization independently of d-glucose concentration (English)

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00265.X

19 March 2024

0 references

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00265.X

19 March 2024

author name string

Anders Wieslander

2

1 reference

4 December 2017

Malcolm Davies

3

1 reference

4 December 2017

Takashi Horiuchi

4

1 reference

4 December 2017

Yuji Ohta

5

1 reference

4 December 2017

Nicholas Topley

9

1 reference

4 December 2017

Llinos W. Morgan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14531821

19 March 2024

M. Janine Beavis

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14531821

19 March 2024

Kathryn J. Craig

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14531821

19 March 2024

John D. Williams

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14531821

19 March 2024

language of work or name

English

0 references

publication date

1 November 2003

1 reference

full work available at URL

4 December 2017

http://www.kidney-international.org/article/S0085253815495390/pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14531821

https://api.elsevier.com/content/article/PII:S0085253815495390?httpAccept=text/xml

19 March 2024

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00265.X

https://api.elsevier.com/content/article/PII:S0085253815495390?httpAccept=text/plain

19 March 2024

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00265.X

19 March 2024

1 reference

4 December 2017

64

1 reference

4 December 2017

5

1 reference

4 December 2017

1854-1866

1 reference

https://scigraph.springernature.com/pub.10.1046/j.1523-1755.2003.00265.x

4 December 2017

0 references

cites work

Membrane longevity in peritoneal dialysis: impact of infection and bio-incompatible solutions

1

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00265.X

Longitudinal follow-up of CA125 in peritoneal effluent

19 March 2024

2

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00265.X

Peritoneal dialysis fluid induces change of mononuclear phagocyte proportions

19 March 2024

4

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00265.X

An autopsy study of the peritoneal cavity from patients on continuous ambulatory peritoneal dialysis

19 March 2024

5

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00265.X

HGF/SF induces mesothelial cell migration and proliferation by autocrine and paracrine pathways

19 March 2024

6

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00265.X

Response of the human peritoneal mesothelial cell to injury: an in vitro model of peritoneal wound healing

19 March 2024

8

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00265.X

Induction of hyaluronan metabolism after mechanical injury of human peritoneal mesothelial cells in vitro

19 March 2024

9

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00265.X

HB-EGF is produced in the peritoneal cavity and enhances mesothelial cell adhesion and migration.

19 March 2024

10

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00265.X

Epidermal growth factor modifies the expression and function of extracellular matrix adhesion receptors expressed by peritoneal mesothelial cells from patients on CAPD.

19 March 2024

11

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00265.X

High glucose induces MCP-1 expression partly via tyrosine kinase-AP-1 pathway in peritoneal mesothelial cells

19 March 2024

12

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00265.X

High glucose-induced PKC activation mediates TGF-beta 1 and fibronectin synthesis by peritoneal mesothelial cells

19 March 2024

13

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00265.X

Glucose-mediated induction of TGF-beta 1 and MCP-1 in mesothelial cells in vitro is osmolality and polyol pathway dependent

19 March 2024

14

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00265.X

Effect of high glucose concentration on the synthesis of monocyte chemoattractant protein-1 in human peritoneal mesothelial cells: involvement of protein kinase C

19 March 2024

15

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00265.X

Toxicity of peritoneal dialysis fluids on cultured fibroblasts, L-929.

19 March 2024

19

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00265.X

Glucose degradation product methylglyoxal enhances the production of vascular endothelial growth factor in peritoneal cells: role in the functional and morphological alterations of peritoneal membranes in peritoneal dialysis

19 March 2024

22

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00265.X

Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose

19 March 2024

24

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00265.X

Accelerated formation of N epsilon-(carboxymethyl) lysine, an advanced glycation end product, by glyoxal and 3-deoxyglucosone in cultured rat sensory neurons.

19 March 2024

25

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00265.X

Vascular endothelial growth factor production and regulation in human peritoneal mesothelial cells

19 March 2024

26

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00265.X

Accumulation of advanced glycation end products in the peritoneal vasculature of continuous ambulatory peritoneal dialysis patients with low ultra-filtration

19 March 2024

27

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00265.X

Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in CAPD

19 March 2024

28

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00265.X

Long-term clinical effects of a peritoneal dialysis fluid with less glucose degradation products

19 March 2024

29

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00265.X

Bicarbonate/lactate-based peritoneal dialysis solution increases cancer antigen 125 and decreases hyaluronic acid levels

19 March 2024

31

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00265.X

In vivo exposure to bicarbonate/lactate- and bicarbonate-buffered peritoneal dialysis fluids improves ex vivo peritoneal macrophage function

19 March 2024

34

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00265.X

Human peritoneal mesothelial cell prostaglandin synthesis: induction of cyclooxygenase mRNA by peritoneal macrophage-derived cytokines

19 March 2024

35

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00265.X

Isolation, culture and characterization of human peritoneal mesothelial cells

19 March 2024

36

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00265.X

3,4-Dideoxyglucosone-3-ene (3,4-DGE): a cytotoxic glucose degradation product in fluids for peritoneal dialysis

19 March 2024

37

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00265.X

In vitro formation of N(epsilon)-(carboxymethyl)lysine and imidazolones under conditions similar to continuous ambulatory peritoneal dialysis

19 March 2024

40

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00265.X

Effect of lactate-buffered peritoneal dialysis fluids on human peritoneal mesothelial cell interleukin-6 and prostaglandin synthesis

19 March 2024

41

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00265.X

Human peritoneal fibroblast proliferation in 3-dimensional culture: modulation by cytokines, growth factors and peritoneal dialysis effluent

19 March 2024

42

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00265.X

Composition of peritoneal dialysis solutions: potential hazards

19 March 2024

43

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00265.X

Peritoneal dialysate fluid composition determines heat shock protein expression patterns in human mesothelial cells

19 March 2024

46

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00265.X

Glucose degradation products in PD fluids: do they disappear from the peritoneal cavity and enter the systemic circulation?

19 March 2024

50

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00265.X

Toxicity of osmotic solutes on human mesothelial cells in vitro

19 March 2024

52

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00265.X

Effect of dwell time on carbonyl stress using icodextrin and amino acid peritoneal dialysis fluids

19 March 2024

54

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00265.X

3-Deoxyglucosone: metabolism, analysis, biological activity, and clinical implication

19 March 2024

55

1 reference

https://api.crossref.org/works/10.1046/J.1523-1755.2003.00265.X

19 March 2024

Identifiers

1 reference

Dimensions Publication ID

4 December 2017

0 references

1 reference